Simultaneous targeting of MCL1 and ABCB1 as a novel strategy to overcome drug resistance in human leukaemia

British Journal of Haematology

Volumn 145, Issue 5, 2009, Pages 648-656

  Ji, Min ^a   Li, Jie ^a   Yu, Haiqing ^a   Ma, Daoxin ^a   Ye, Jingjing ^a   Sun, Xiulian ^a   Ji, Chunyan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

ABCB1; Drug resistance; Leukaemia; MCL1; RNA interference

Indexed keywords

DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN MCL 1; SHORT HAIRPIN RNA;

APOPTOSIS; ARTICLE; CELL STRAIN K 562; CLINICAL ARTICLE; DOWN REGULATION; DRUG SENSITIVITY; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CHI-SQUARE DISTRIBUTION; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; LEUKEMIA; P-GLYCOPROTEIN; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 66149097016     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07678.x     Document Type: Article

References (30)

1. Aichberger, K.J., Mayerhofer, M., Krauth, M.T., Skvara, H., Florian, S., Sonneck, K., Akgul, C., Derdak, S., Pickl, W.F., Wacheck, V., Selzer, E., Monia, B.P., Moriggl, R., Valent, P. Sillaber, C. (2005) Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides. Blood, 105, 3303 3311.
2. Awan, F.T., Kay, N.E., Davis, M.E., Wu, W., Geyer, S.M., Leung, N., Jelinek, D.F., Tschumper, R.C., Secreto, C.R., Lin, T.S., Grever, M.R., Shanafelt, T.D., Zent, C.S., Call, T.G., Heerema, N.A., Lozanski, G., Byrd, J.C. Lucas, D.M. (2009) Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab. Blood, 113, 535 537.
3. Baran, Y., Gür, B., Kaya, P., Ural, A.U., Avcu, F. Gündüz, U. (2007) Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance. Hematology, 12, 511 517. (Pubitemid 350048061)
4. Chetoui, N., Sylla, K., Gagnon-Houde, J.V., Alcaide-Loridan, C., Charron, D., Al-Daccak, R. Aoudjit, F. (2008) Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Molecular Cancer Research, 6, 42 52.
5. L is an essential survival protein of human myeloma cells. Blood, 100, 194 199. (Pubitemid 35177447)
6. Ding, Q., He, X., Xia, W., Hsu, J.M., Chen, C.T., Li, L.Y., Lee, D.F., Yang, J.Y., Xie, X., Liu, J.C. Hung, M.C. (2007) Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer. Cancer Research, 67, 4564 4571. (Pubitemid 46910160)
7. Dzhagalov, I., St John, A. He, Y.W. (2007) The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. Blood, 109, 1620 1626. (Pubitemid 46239596)
8. Gomez-Bougie, P., Wuillème-Toumi, S., Ménoret, E., Trichet, V., Robillard, N., Philippe, M., Bataille, R. Amiot, M. (2007) Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma. Cancer Research, 67, 5418 5424. (Pubitemid 46997282)
9. Ho, M.M., Hogge, D.E. Ling, V. (2008) MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia. Experimental Hematology, 36, 433 442.
10. Hussain, S.R., Cheney, C.M., Johnson, A.J., Lin, T.S., Grever, M.R., Caligiuri, M.A., Lucas, D.M. Byrd, J.C. (2007) Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity. Clinical Cancer Research, 13, 2144 2150. (Pubitemid 46649884)
11. Inoue, S., Walewska, R., Dyer, M.J. Cohen, G.M. (2008) Downregulation of Mcl-1 potentiates HDACi-mediated apoptosis in leukemic cells. Leukemia, 22, 819 825.
12. Kang, M.H., Wan, Z., Kang, Y.H., Sposto, R. Reynolds, C.P. (2008) Mechanism of synergy of N-(4-Hydroxyphenyl) retinamide and ABT-737 in acute lymphoblastic leukemia cell line: Mcl-1 inactivation. Journal of the National Cancer Institute, 100, 580 595.
13. Kaufmann, S.H., Karp, J.E., Svingen, P.A., Krajewski, S., Burke, P.J., Gore, S.D. Reed, J.C. (1998) Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. Blood, 91, 991 1000. (Pubitemid 28078303)
14. Kozopas, K.M., Yang, T., Buchan, H.L., Zhou, P. Craig, R.W. (1993) MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proceedings of the National Academy of Sciences of the United States of America, 90, 3516 3520.
15. Leith, C.P., Kopecky, K.J., Godwin, J., McConnell, T., Slovak, M.L., Chen, I.M., Head, D.R., Appelbaum, F.R. Willman, C.L. (1997) Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood, 89, 3323 3329.
16. Leith, C.P., Kopecky, K.J., Chen, I.M., Eijdems, L., Slovak, M.L., McConnell, T.S., Head, D.R., Weick, J., Grever, M.R., Appelbaum, F.R. Willman, C.L. (1999) Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study. Blood, 94, 1086 1099. (Pubitemid 29361842)
17. Moulding, D.A., Giles, R.V., Spiller, D.G., White, M.R., Tidd, D.M. Edwards, S.W. (2000) Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells. Blood, 96, 1756 1763. (Pubitemid 30661059)
18. Nencioni, A., Hua, F., Dillon, C.P., Yokoo, R., Scheiermann, C., Cardone, M.H., Barbieri, E., Rocco, I., Garuti, A., Wesselborg, S., Belka, C., Brossart, P., Patrone, F. Ballestrero, A. (2005) Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis. Blood, 105, 3255 3262.
19. Opferman, J.T., Letai, A., Beard, C., Sorcinelli, M.D., Ong, C.C. Korsmeyer, S.J. (2003) Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature, 426, 671 676. (Pubitemid 38009376)
20. Opferman, J.T., Iwasaki, H., Ong, C.C., Suh, H., Mizuno, S., Akashi, K. Korsmeyer, S.J. (2005) Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science, 307, 1101 1104. (Pubitemid 40262114)
21. Pepper, C., Lin, T.T., Pratt, G., Hewamana, S., Brennan, P., Hiller, L., Hills, R., Ward, R., Starczynski, J., Austen, B., Hooper, L., Stankovic, T. Fegan, C. (2008) Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood, 112, 3807 3817.
22. Ruefli, A.A., Tainton, K.M., Darcy, P.K., Smyth, M.J. Johnstone, R.W. (2002) P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation. Cell Death and Differentiation, 9, 1266 1272. (Pubitemid 35331774)
23. Saxena, A., Viswanathan, S., Moshynska, O., Tandon, P., Sankaran, K. Sheridan, D.P. (2004) Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia. American Journal of Hematology, 75, 22 33. (Pubitemid 38040164)
24. Schaich, M., Soucek, S., Thiede, C., Ehninger, G., Illmer, T. SHG AML96 Study Group 2005) MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. British Journal of Haematology, 128, 324 332. (Pubitemid 40216154)
25. Schulze-Bergkamen, H., Fleischer, B., Schuchmann, M., Weber, A., Weinmann, A., Krammer, P.H. Galle, P.R. (2006) Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. BMC Cancer, 6, 232.
26. Shimizu, S., Narita, M. Tsujimoto, Y. (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 399, 483 487. (Pubitemid 29258855)
27. Sikic, B.I. (2006) Multidrug resistance and stem cells in acute myeloid leukemia. Clinical Cancer Research, 12, 3231 3232. (Pubitemid 43910862)
28. Song, L., Coppola, D., Livingston, S., Cress, D. Haura, E.B. (2005) Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells. Cancer Biology & Therapy, 4, 267 276. (Pubitemid 41351285)
29. Tallman, M.S., Gilliland, D.G. Rowe, J.M. (2005) Drug therapy for acute myeloid leukemia. Blood, 106, 1154 1163. (Pubitemid 41130866)
30. Taniai, M., Grambihler, A., Hiquchi, H., Werneburg, N., Bronk, S.F., Farrugia, D.J., Kaufmann, S.H. Gores, G.J. (2004) Mcl-1 mediates tumor necrosis fator-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells. Cancer Research, 64, 3517 3524. (Pubitemid 38657926)